Driving the Speed of Adoption with Decentralized Clinical Trials
Biopharma companies and contract research organizations (CROs) adopted decentralized or digital clinical trials (DCTs) to reduce contact, improve the patient experience and keep studies on track during the pandemic. It’s already clear that the virtual approach of DCTs are benefiting life science organizations. From improvements in clinical trial operations such as enhanced patient engagement and site experience to cost savings and better data integration, the clinical trial dynamic has shifted and supports DCTs as a legitimate way to execute studies.
Executive Summary: Uncovering the Missing Link in AI-Enhanced Field Rep Support
March 4th 2025AI-powered knowledge assistants are transforming pharmaceutical sales by providing field reps with instant access to accurate and compliant information, addressing challenges related to information overload and inconsistent messaging.
How to Transform Real-World Evidence (RWE) Insights with Innovative Data Solutions
January 27th 2025Organizations that focus on improving patient outcomes and reducing healthcare costs rely on real-world data to guide and support their mission. Being able to extract meaningful insights from this data is vital.
What Every Pharma CEO Should Know About Unlocking Scientific Data Potential
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
